<DOC>
	<DOCNO>NCT02504437</DOCNO>
	<brief_summary>The purpose present study evaluate efficacy precondition autologous bone marrow mesenchymal stem cell patient ischemic heart disease .</brief_summary>
	<brief_title>Therapy Preconditioned Autologous BMMSCs Patients With Ischemic Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Age 75 ; Clinical diagnosis acute Myocardial Infarction , chronic Myocardial Infarction Ischemic Cardiomyopathy NYHA ( New York Heart Association ) grade : IIIIV , LVEF ( leave ventricular ejection fraction ) : 2550 % ; No infection diseases include HBV ( hepatitis B virus ) , HCV ( hepatitis C virus ) , syphilis AIDS ; No psychiatric illness speak dysfunction ; Informed consent . More 75 year old ; LVEF &lt; 24 % ; Unstable hemodynamics , shock ; Severe infection ; Patients tumor lethal disease ( expectation life &lt; 6 month ) ; Radiation patient ; hematopoietic malignancy include Haemophiliacs ; Anemia ( Hb &lt; 100g/L ) ; The clinical trial participant within one month ; Abnormal increase blood biochemical indicator explain condition ; Informed refusal .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>